By proceeding, you agree to our Terms of Use and Privacy Policy.
Senior Director
#immuno-oncology
#NorthAmerica
David DiLillo is a Staff Scientist in the Immuno-Oncology department at Regeneron Pharmaceuticals in New York, where he leads a team investigating novel T cell-retargeting technologies. His team is re
Director, Immuno-Oncology
#immuno-oncology #safety #efficacy
I am the Director of Immuno-Oncology at Soteria Biotherapeutics, a Series A-funded biotech located in San Francisco. We are developing switchable bispecific T-cell engagers to enable the treatment of
Director
#drugdevelopment #immuno-oncology
#Europe
George Svitel is a Director of Formulation and Drug Product Development at NGM Biopharmaceuticals Inc. Prior to NGM Bio, he was with Merck, Amgen and National Institutes of Health.
Senior Principal Scientist, Immuno-Oncology and Cellular Therapy
#Immuno-Oncology #CellularTherapy
Immunologist and principal investigator specializing in innate and adaptive immune mechanisms of host and engineered responses to infections and malignancies. Possesses a record of success in advancin
Executive Medical Director - Cell Therapies and Immuno-OncologyExecutive Medical Director - Cell Therapies and Immuno-Oncology
#CellTherapies #Immuno-Oncology
Adaptive clinical trial designs, Bayes acolyte, immune-imaging using novel PET-based technologies.
Head of Laboratory, the Ella Lemelbaum Institute of Immuno Oncology
#immuno-oncology #clinicalimmunology
#MiddleEast
Head of Laboratory at the Ella Lemelbaum Institute for Immuno-Oncology and the Director of the Wohl GMP facility at the Sheba Medical Center in Israel.
Chief Business Officer
#immuno-oncology #infectiousdisease
Nell Beattie is the Chief Business Officer at VBI Vaccines, and has been with the company since 2015.
Billy Wilder Endowed Professor and Chair
#Northamerica
Peter P. Lee, M.D., is the chair of the Department of Immuno-Oncology at Beckman Research Institute of City of Hope and a beneficiary of The Christopher Family Endowed Innovation Fund for Alzheimer’s
Medical Director
#immuno-oncology #chemotherapeuticdrugs
Sonia Maciá, MD, is an ESMO-certified Medical Oncologist. Dr. Maciá worked as a practicing Medical Oncologist for nine years and then decided to devote her career to clinical research.